v3.26.3
Note 1 - Nature of the Business and the Basis of Preparation - Schedule of Subsidiaries (Details)
Sep. 30, 2026
BeyondSpring U.S. [Member]  
Percentage of ownership by the Group 100.00%
BeyondSpring Pharmaceuticals Australia PTY Ltd. (“BeyondSpring Australia”) [Member]  
Percentage of ownership by the Group 100.00%
BVI Biotech [Member]  
Percentage of ownership by the Group 100.00%